AHRQ FY19 Grant Cycle Research Funding Opportunities
This webinar, hosted jointly by SHEA and the Agency for Healthcare Research and Quality (AHRQ), discusses research funding opportunities for the Fiscal Year 2019 grant cycle. Prospective AHRQ grantees will hear about requirements and recommendations for a strong R01 application. This webinar is presented by James I. Cleeman, MD, Senior Medical Officer and Director of the Division of Healthcare-Associated Infections (HAI), and Melissa Miller, MD, MS, Medical Officer in the Division of HAIs, both of the Center for Quality Improvement and Patient Safety at AHRQ.
Important information about 2019 funding application deadlines
Funding applications are due by January 25, 2019 for demonstration and dissemination projects (R18). Applications are due by February 5, 2019 for large research projects (R01). HAI projects in both grant categories should demonstrate new ways to detect, prevent and reduce HAIs. Combating antibiotic resistant bacteria (CARB) projects should address ways to promote appropriate antibiotic use, reduce the transmission of resistant bacteria or prevent HAIs. To learn more, access the "Research Funding Available" section at the top of AHRQ's Healthcare-Associated Infections Program page.
Learning Objectives
Topics covered in this webinar include:
- An overview of AHRQ's Patient Safety Research Program and the process for its targeted grant funding announcements, application cycles and their relationship to due dates, review and council dates, and earliest possible start dates;
- A description of active program announcements and requests for applications related to the prevention and control of HAIs to develop improved methods for preventing HAIs and to develop effective implementation strategies for HAI prevention in all health care settings;
- An outline of AHRQ’s HAI research portfolio and a discussion about the types of studies the agency is interested in funding, such as research in combating antibiotic resistant bacteria, promoting appropriate antibiotic use, and reducing the transmission of resistant bacteria.
Panelists:
- Dr. James Cleeman (james.cleeman@ahrq.hhs.gov)
- Dr. Melissa Miller (melissa.miller@ahrq.hhs.gov)
Organizers:
Lynne Batshon (lbatshon@shea-online.org)